Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Cystotech ApS
APS
Active
Advertising protection
CVR 42773565
Inge Lehmanns Gade 10, 8000
Aarhus C
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
16 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cystotech ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
2M
2M
1M
1M
0M
2022: 1M
1M
2022
2023: 2M (+100% vs 2022)
2M
+100%
2023
2024: 1M (-50% vs 2023)
1M
-50%
2024
2025: 2M (+100% vs 2024)
2M
+100%
2025
EBITDA
DKK millions
0M
-2M
-3M
-5M
-6M
2022: -1M
-1M
2022
2023: -2M (-100% vs 2022)
-2M
-100%
2023
2024: -4M (-100% vs 2023)
-4M
-100%
2024
2025: -5M (-25% vs 2024)
-5M
-25%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
Gross profit
1.528
877
1.612
765
Staff expenses
-6.567
-4.907
-3.326
-1.390
EBITDA
-5.038
-4.030
-1.714
-625
Depreciation & amort.
-11
-0
-0
-0
EBIT
-5.050
-4.030
-1.714
-625
Net financials
-507
-465
-402
-183
Profit before tax
-5.557
-4.495
-2.116
-808
Tax
-1.175
-1.041
-519
-270
Net profit
-4.382
-3.454
-1.597
-538
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
Total assets
32.169
16.540
13.621
8.153
Equity
24.841
9.495
7.603
4.119
Long-term debt
4.499
4.009
3.525
3.107
Short-term debt
2.830
2.997
2.285
891
Total debt
7.328
7.006
5.810
3.998
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-329,7 %
This company
2022
2025
Equity ratio
77,2 %
This company
38,2 %
Market median
This company
Market median
102% above market
2022
2025
Return on equity
-17,6 %
This company
18,4 %
Market median
This company
Market median
196% below market
2022
2025
Net profit margin (of gross profit)
-286,8 %
This company
2022
2025
Asset turnover (of gross profit)
0,05×
This company
2022
2025
Debt / equity
0,30×
This company
0,62×
Market median
This company
Market median
52% below market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-20 – 2022-12-31
View
PDF
More on Cystotech ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
